Hold: 15-20% tactical tranche at $171 with $162 stop, 80-85% capital reserved for better entry at $150-160 or $185+ breakout
Hold with executable engagement path. The 15-20% tactical tranche at $171 with $162 hard stop directly addresses the documented failure mode from prior PLTR Holds (8/10 produced +0.2% alpha, 8/11 produced -2.5% alpha). While fundamentals are excellent (93% YoY revenue, $9.4B net cash, 47.1% margins), 74x forward P/E justifies reserving 80-85% of capital for better entry. Prior Aggressive Analyst's full-size entry at this valuation repeated the survivorship bias error; prior Conservative Analyst missed the opportunity cost of passive observation. The Neutral Analyst's asymmetric sizing—small controlled loss probability, patient capital for better levels, capped concentration at 5-10% portfolio—provides the only synthesis that avoids documented failure modes while maintaining exposure to loaded catalyst pipeline.
| Position | Action |
|---|---|
| Current setup (15-20% tranche) | Deploy 15-20% of intended position at $171 with hard stop at $162 |
| Pullback to $150-160 with golden cross confirmation | Deploy 80-85% of reserved capital |
| Weekly close above $185 on volume >75M shares | Consider increasing position toward full sizing |
| Q3 2026 revenue growth below 70% YoY OR weekly close below $152 | Downgrade to Underweight |
| Total portfolio exposure | Cap PLTR at 5-10% of portfolio maximum |
Palantir's accelerating revenue growth (93% YoY), expanding margins (47% operating, 49% net), fortress balance sheet ($9.2B net cash), and dominant moat in defense/intelligence AI deployment justify premium valuation and support continued upside.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $158.53 | bullish |
| 50 SMA | $133.81 | bullish |
| 200 SMA | $152.20 | bullish |
| RSI (14) | 69.75 | neutral |
| MACD | +11.25 (Signal: +6.34, Histogram: +4.90) | bullish |
| Bollinger Middle Band | $141.22 | bullish |
| Bollinger Upper Band | $182.11 | neutral |
| Bollinger Lower Band | $100.33 | bearish |
| ATR (14) | $8.54 (~5.0% daily range) | neutral |
| VWMA (20-day) | $150.18 | bullish |
Support: 100.33 · 122.26 · 133.81 · 152.2 · 158.53 · 162.66 | Resistance: 171.04 · 175.23 · 182.11 · 190
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed weekly close above $185 on volume exceeding 75M shares
Then: Consider full position sizing
Operating margins are expanding faster than revenue, demonstrating hyper-scale operating leverage
↩ rebuts: “Bear case that premium valuation isn't supported by profitability”
EV: +$190+ (target) · concedes: Polymarket-implied 33% probability of September Fed hike; Premium valuation requires continued execution; SBC dilution (~7% diluted vs basic) is real; Recession odds at 8%; Smart money selling is factually accurate even if analytically flawed
At 150x trailing P/E and 73.9x forward P/E, the stock is priced for perfection and offers no margin of safety; the bull's $300 thesis requires four unprecedented assumptions stacked together, while the bear's downside case requires just one adverse outcome to materialize.
EV: -$120 to -$152 (downside scenarios with mean reversion or multiple compression) · concedes: Q2 2026 was operationally extraordinary with 93% revenue growth and $1.94B quarter; FDE model is real and the integration is real; procurement barriers in defense are genuine; Deferred revenue up 60% YoY is genuinely bullish as a leading indicator; 49% TTM net margin is still elite even at the corrected 40% operating margin; $9.4B cash provides insulation even if not material to valuation; The company is operationally executing and the business is not broken
→ vs conservative: Volume drop 80% after August 4 breakout is post-breakout consolidation, not textbook institutional distribution—if institutions were distributing, price would have closed below $162.66 breakout level, which hasn't happened once
→ vs conservative: 74x forward P/E framework is wrong—PLTR's 47% operating margin and $9.4B net cash differentiate it from every SaaS comp that decelerated at $2B run-rate; traditional comp set doesn't apply to sovereign AI operating system
→ vs conservative: 'Death cross' technical concern is lagging indicator noise—the price has run so far ahead of both SMAs that bullish crossover is mathematically inevitable within weeks if momentum holds
→ vs neutral: HOLD's 'wait for pullback to $150-160 or breakout above $185' is expensive procrastination that forfeits Q3 earnings catalyst exposure in November and assumes unlimited patience with zero opportunity cost
→ vs neutral: Waiting for breakout above $185 means missing 8% of the move—'disciplined patience' optimizes for feeling smart rather than generating alpha in a confirmed uptrend
→ vs conservative: Polymarket macro tail risks already substantially priced at 33% probability; PLTR demonstrated absorption of macro overhang by declining only 2.2% on hawkish CPI while the stock trades on its own fundamentals
PLTR exhibits a fully aligned bullish technical setup with price above all three key moving averages, MACD momentum expanding positively, and RSI at 69.75 (strong but not overbought). The August 4 gap-up breakout on 175M volume was confirmed as structurally bullish, with today's pullback (-2.2% to $171.04) representing healthy consolidation rather than distribution. Critical support sits at $162.66 (August 4 close), with $182.11 as first resistance and $190+ as the measured move target. Elevated ATR of $8.54 (~5% daily range) warrants wider position stops.
Market Cap
$411.0 B
Beta
1.563
52-Week High
$207.52
52-Week Low
$106.37
50-Day Moving Average
$133.61
200-Day Moving Average
$152.24
Q2 2026 Revenue
$1,935.5 M
TTM Revenue
$6.16 B
Gross Margin
84.7%
Operating Income
$912.0 M
Operating Margin
47.1%
Net Income
$1,061.9 M
Net Margin
49.0%
Diluted EPS
$0.41
TTM EPS
$1.17
Forward EPS
$2.31
TTM EBITDA
$2.66 B
Q2 2026 Operating Cash Flow
$1,216 M
Q2 2026 Free Cash Flow
$1,201.6 M
TTM Free Cash Flow
$2.16 B
FCF Margin
~35%
Cash & Equivalents
$2,030.0 M
Short-Term Investments
$7,379.1 M
Total Liquid Assets
$9.41 B
Total Debt
$211.4 M
Net Cash
~$9.20 B
Current Ratio
7.23
Return on Equity (ROE)
38.1%
Return on Assets (ROA)
17.3%
P/E (TTM)
146.2x
Forward P/E
73.9x
PEG Ratio
2.41
P/B
41.99x
P/S (TTM)
~66.8x
SBC (Q2 2026)
$265.2 M
Dilution Overhang
~7%
AR (Q2 2026)
$1,485 M
Deferred Revenue (Current)
$1.03 B
Stockholders' Equity
$9,774.2 M
Strengths
Concerns
Palantir is executing at an elite level with 93% YoY revenue growth and 47.1% operating margin, generating $2.16B in TTM free cash flow from a fortress balance sheet with $9.2B in net cash. However, the stock trades at a Forward P/E of 73.9x and PEG of 2.41, pricing in hyper-growth continuation with little room for deceleration. High beta (1.563), significant SBC dilution (~7%), and rapidly growing receivables (+99% YoY) are key risks to monitor, particularly any slowdown in government spending or commercial AIP adoption.
Macro: The macro backdrop is characterized by a hawkish Fed repricing cycle: in-line July CPI (+0.1% MoM) supports a soft landing but prevents aggressive dovish cuts, with Polymarket now pricing 33% September hike odds and 86% probability of no cuts in 2026. Recession risk is low (8%), global equities are mixed but Nasdaq is charging higher on AI earnings, and oil is edging up on US-Iran talks deadlock. This hawkish repricing is the single most underappreciated macro risk for high-multiple software names like PLTR.